{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T20:29:45Z","timestamp":1787689785030,"version":"build-2784847793"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T00:00:00Z","timestamp":1633478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T00:00:00Z","timestamp":1633478400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA02812"],"award-info":[{"award-number":["DA02812"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32DA043469"],"award-info":[{"award-number":["T32DA043469"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s00213-021-05991-9","type":"journal-article","created":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T09:20:40Z","timestamp":1633512040000},"page":"1735-1747","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults"],"prefix":"10.1007","volume":"239","author":[{"given":"Conor H.","family":"Murray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Tare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire M.","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Malina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Royce","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriet","family":"de Wit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,6]]},"reference":[{"key":"5991_CR1","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S0028-3908(97)00051-8","volume":"36","author":"GK Aghajanian","year":"1997","unstructured":"Aghajanian GK, Marek GJ (1997) Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells. Neuropharmacol 36:589\u2013599","journal-title":"Neuropharmacol"},{"key":"5991_CR2","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/hbm.23052","volume":"37","author":"MA Albrecht","year":"2016","unstructured":"Albrecht MA, Roberts G, Price G, Lee J, Iyyalol R, Martin-Iverson MT (2016) The effects of dexamphetamine on the resting-state electroencephalogram and functional connectivity. Hum Brain Mapp 37:570\u2013588","journal-title":"Hum Brain Mapp"},{"key":"5991_CR3","doi-asserted-by":"publisher","first-page":"9870","DOI":"10.1073\/pnas.0700436104","volume":"104","author":"JC Beique","year":"2007","unstructured":"Beique JC, Imad M, Mladenovic L, Gingrich JA, Andrade R (2007) Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex. Proc Natl Acad Sci U S A 104:9870\u20139875","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5991_CR4","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.biopsych.2019.05.019","volume":"86","author":"AK Bershad","year":"2019","unstructured":"Bershad AK, Schepers ST, Bremmer MP, Lee R, de Wit H (2019) Acute subjective and behavioral effects of microdoses of lysergic acid diethylamide in healthy human volunteers. Biol Psychiatry 86:792\u2013800","journal-title":"Biol Psychiatry"},{"key":"5991_CR5","first-page":"461","volume":"5","author":"AK Bershad","year":"2020","unstructured":"Bershad AK, Preller KH, Lee R, Keedy S, Wren-Jarvis J, Bremmer MP, de Wit H (2020) Preliminary report on the effects of a low dose of lsd on resting-state amygdala functional connectivity. Biol Psychiatry Cogn Neurosci Neuroimaging 5:461\u2013467","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"5991_CR6","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00213-017-4807-2","volume":"235","author":"A Bravermanova","year":"2018","unstructured":"Bravermanova A, Viktorinova M, Tyls F, Novak T, Androvicova R, Korcak J, Horacek J, Balikova M, Griskova-Bulanova I, Danielova D, Vlcek P, Mohr P, Brunovsky M, Koudelka V, Palenicek T (2018) Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing-study on P300 and mismatch negativity in healthy volunteers. Psychopharmacol (Berl) 235:491\u2013503","journal-title":"Psychopharmacol (Berl)"},{"key":"5991_CR7","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.neuron.2012.09.029","volume":"76","author":"TJ Buschman","year":"2012","unstructured":"Buschman TJ, Denovellis EL, Diogo C, Bullock D, Miller EK (2012) Synchronous oscillatory neural ensembles for rules in the prefrontal cortex. Neuron 76:838\u2013846","journal-title":"Neuron"},{"key":"5991_CR8","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1124\/pr.118.017160","volume":"71","author":"RL Carhart-Harris","year":"2019","unstructured":"Carhart-Harris RL, Friston KJ (2019) REBUS and the anarchic brain: toward a unified model of the brain action of psychedelics. Pharmacol Rev 71:316\u2013344","journal-title":"Pharmacol Rev"},{"key":"5991_CR9","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1073\/pnas.1119598109","volume":"109","author":"RL Carhart-Harris","year":"2012","unstructured":"Carhart-Harris RL, Erritzoe D, Williams T, Stone JM, Reed LJ, Colasanti A, Tyacke RJ, Leech R, Malizia AL, Murphy K, Hobden P, Evans J, Feilding A, Wise RG, Nutt DJ (2012) Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proc Natl Acad Sci U S A 109:2138\u20132143","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5991_CR10","doi-asserted-by":"publisher","first-page":"4853","DOI":"10.1073\/pnas.1518377113","volume":"113","author":"RL Carhart-Harris","year":"2016","unstructured":"Carhart-Harris RL et al (2016) Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proc Natl Acad Sci U S A 113:4853\u20134858","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5991_CR11","doi-asserted-by":"crossref","unstructured":"Delorme A, Makeig S (2004) EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis. J Neurosci Methods 134:9\u201321","DOI":"10.1016\/j.jneumeth.2003.10.009"},{"key":"5991_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/bs.pbr.2018.07.008","volume":"242","author":"D De Gregorio","year":"2018","unstructured":"De Gregorio D, Enns JP, Nunez NA, Posa L, Gobbi G (2018) d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: mechanism of action and potential therapeutic applications in mood disorders. Prog Brain Res 242:69\u201396","journal-title":"Prog Brain Res"},{"issue":"Suppl 2","key":"5991_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1055\/s-2007-979351","volume":"31","author":"A Dittrich","year":"1998","unstructured":"Dittrich A (1998) The standardized psychometric assessment of altered states of consciousness (ASCs) in humans. Pharmacopsychiatry 31(Suppl 2):80\u201384","journal-title":"Pharmacopsychiatry"},{"key":"#cr-split#-5991_CR14.1","unstructured":"Eckman P, Friesen W (1976) Pictures of facial affect. Consorting Psychologies' Press, Palo Alto CA"},{"key":"#cr-split#-5991_CR14.2","doi-asserted-by":"crossref","unstructured":"Folkman S, Chesney M, McKusick L, Ironson G, Johnson DS, Coates TJ (1991) Translating Coping Theory into an Intervention. The Social Context of Coping, S:239-260.","DOI":"10.1007\/978-1-4899-3740-7_11"},{"key":"5991_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.neuroimage.2009.01.050","volume":"46","author":"D Erritzoe","year":"2009","unstructured":"Erritzoe D, Frokjaer VG, Haugbol S, Marner L, Svarer C, Holst K, Baar\u00e9 WF, Rasmussen PM, Madsen J, Paulson OB, Knudsen GM (2009) Brain serotonin 2A receptor binding: relations to body mass index, tobacco and alcohol use. Neuroimage 46:23\u201330","journal-title":"Neuroimage"},{"key":"5991_CR16","unstructured":"Fadiman J (2011) The psychedelic explorer\u2019s guide: safe, therapeutic, and sacred journeys: Inner Traditions\/Bear."},{"key":"5991_CR17","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1080\/02791072.2019.1593561","volume":"51","author":"J Fadiman","year":"2019","unstructured":"Fadiman J, Korb S (2019) Might microdosing psychedelics be safe and beneficial? An Initial Exploration. J Psychoactive Drugs 51:118\u2013122","journal-title":"J Psychoactive Drugs"},{"key":"5991_CR18","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00213-019-05417-7","volume":"237","author":"N Family","year":"2020","unstructured":"Family N, Maillet EL, Williams LTJ, Krediet E, Carhart-Harris RL, Williams TM, Nichols CD, Goble DJ, Raz S (2020) Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers. Psychopharmacol (Berl) 237:841\u2013853","journal-title":"Psychopharmacol (Berl)"},{"key":"5991_CR19","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1111\/j.1360-0443.1991.tb01749.x","volume":"86","author":"MW Fischman","year":"1991","unstructured":"Fischman MW, Foltin RW (1991) Utility of subjective-effects measurements in assessing abuse liability of drugs in humans. Br J Addict 86:1563\u20131570","journal-title":"Br J Addict"},{"key":"5991_CR20","doi-asserted-by":"crossref","unstructured":"Gao C, Conte S, Richards JE, Xie W, Hanayik T (2019) The neural sources of N170: Understanding timing of activation in face-selective areas. Psychophysiology 56:e13336.","DOI":"10.1111\/psyp.13336"},{"key":"5991_CR21","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1172\/JCI130808","volume":"130","author":"DM Gerhard","year":"2020","unstructured":"Gerhard DM, Pothula S, Liu RJ, Wu M, Li XY, Girgenti MJ, Taylor SR, Duman CH, Delpire E, Picciotto M, Wohleb ES, Duman RS (2020) GABA interneurons are the cellular trigger for ketamine\u2019s rapid antidepressant actions. J Clin Invest 130:1336\u20131349","journal-title":"J Clin Invest"},{"key":"5991_CR22","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","volume":"30","author":"RR Griffiths","year":"2016","unstructured":"Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD, Cosimano MP, Klinedinst MA (2016) Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial. J Psychopharmacol 30:1181\u20131197","journal-title":"J Psychopharmacol"},{"key":"5991_CR23","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.euroneuro.2018.03.016","volume":"28","author":"O Grimm","year":"2018","unstructured":"Grimm O, Kraehenmann R, Preller KH, Seifritz E, Vollenweider FX (2018) Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination. Eur Neuropsychopharmacol 28:691\u2013700","journal-title":"Eur Neuropsychopharmacol"},{"key":"5991_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/BF02584088","volume":"4","author":"CA Haertzen","year":"1963","unstructured":"Haertzen CA, Hill HE, Belleville RE (1963) Development of the Addiction Research Center Inventory (Arci): selection of items that are sensitive to the effects of various drugs. Psychopharmacologia 4:155\u2013166","journal-title":"Psychopharmacologia"},{"key":"5991_CR25","doi-asserted-by":"crossref","unstructured":"Hutten N, Mason NL, Dolder PC, Theunissen EL, Holze F, Liechti ME, Feilding A, Ramaekers JG, Kuypers KPC (2020) Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled doseeffect finding study. Eur Neuropsychopharmacol 41:81\u201391","DOI":"10.1016\/j.euroneuro.2020.10.002"},{"key":"5991_CR26","first-page":"39","volume":"35","author":"PG Johnstad","year":"2018","unstructured":"Johnstad PG (2018) Powerful substances in tiny amounts: an interview study of psychedelic microdosing. Nordisk Alkohol Nark 35:39\u201351","journal-title":"Nordisk Alkohol Nark"},{"key":"5991_CR27","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/BF00429064","volume":"45","author":"PH Kelly","year":"1975","unstructured":"Kelly PH, Iversen LL (1975) LSD as an agonist at mesolimbic dopamine receptors. Psychopharmacologia 45:221\u2013224","journal-title":"Psychopharmacologia"},{"key":"5991_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.brainresrev.2006.06.003","volume":"53","author":"W Klimesch","year":"2007","unstructured":"Klimesch W, Sauseng P, Hanslmayr S (2007) EEG alpha oscillations: the inhibition-timing hypothesis. Brain Res Rev 53:63\u201388","journal-title":"Brain Res Rev"},{"key":"5991_CR29","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.1007\/s00213-015-4026-7","volume":"232","author":"M Kometer","year":"2015","unstructured":"Kometer M, Pokorny T, Seifritz E, Volleinweider FX (2015) Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations. Psychopharmacol (Berl) 232:3663\u20133676","journal-title":"Psychopharmacol (Berl)"},{"key":"5991_CR30","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1177\/0269881119857204","volume":"33","author":"KP Kuypers","year":"2019","unstructured":"Kuypers KP, Ng L, Erritzoe D, Knudsen GM, Nichols CD, Nichols DE, Pani L, Soula A, Nutt D (2019) Microdosing psychedelics: more questions than answers? An overview and suggestions for future research. J Psychopharmacol 33:1039\u20131057","journal-title":"J Psychopharmacol"},{"key":"5991_CR31","first-page":"669","volume":"62","author":"KPC Kuypers","year":"2020","unstructured":"Kuypers KPC (2020) Microdosing with psychedelics: what do we know? Tijdschr Psychiatr 62:669\u2013676","journal-title":"Tijdschr Psychiatr"},{"key":"5991_CR32","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s00213-010-2031-4","volume":"213","author":"MM Lansbergen","year":"2011","unstructured":"Lansbergen MM, Dumont GJ, van Gerven JM, Buitelaar JK, Verkes RJ (2011) Acute effects of MDMA (3,4-methylenedioxymethamphetamine) on EEG oscillations: alone and in combination with ethanol or THC (delta-9-tetrahydrocannabinol). Psychopharmacol (Berl) 213:745\u2013756","journal-title":"Psychopharmacol (Berl)"},{"key":"5991_CR33","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1002\/hbm.22833","volume":"36","author":"AV Lebedev","year":"2015","unstructured":"Lebedev AV, Lovden M, Rosenthal G, Feilding A, Nutt DJ, Carhart-Harris RL (2015) Finding the self by losing the self: neural correlates of ego-dissolution under psilocybin. Hum Brain Mapp 36:3137\u20133153","journal-title":"Hum Brain Mapp"},{"key":"5991_CR34","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1002\/hbm.23234","volume":"37","author":"AV Lebedev","year":"2016","unstructured":"Lebedev AV, Kaelen M, Lovden M, Nilsson J, Feilding A, Nutt DJ, Carhart-Harris RL (2016) LSD-induced entropic brain activity predicts subsequent personality change. Hum Brain Mapp 37:3203\u20133213","journal-title":"Hum Brain Mapp"},{"key":"5991_CR35","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0005-7967(94)00075-U","volume":"33","author":"PF Lovibond","year":"1995","unstructured":"Lovibond PF, Lovibond SH (1995) The structure of negative emotional states: comparison of the depression anxiety stress scales (DASS) with the beck depression and anxiety inventories. Behav Res Ther 33:335\u2013343","journal-title":"Behav Res Ther"},{"key":"5991_CR36","doi-asserted-by":"crossref","unstructured":"Luppi AI, Carhart-Harris RL, Roseman L, Pappas I, Menon DK, Stamatakis EA (2021) LSD alters dynamic integration and segregation in the human brain. Neuroimage 227:117653.","DOI":"10.1016\/j.neuroimage.2020.117653"},{"key":"5991_CR37","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/cpt1971122part1245","volume":"12","author":"WR Martin","year":"1971","unstructured":"Martin WR, Sloan JW, Sapira JD, Jasinski DR (1971) Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther 12:245\u2013258","journal-title":"Clin Pharmacol Ther"},{"key":"5991_CR38","unstructured":"McNair DM, Lorr M, Droppleman LF (1971) Manual profile of mood states."},{"key":"5991_CR39","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00213-012-2954-z","volume":"227","author":"ME Morean","year":"2013","unstructured":"Morean ME, de Wit H, King AC, Sofuoglu M, Rueger SY, O\u2019Malley SS (2013) The drug effects questionnaire: psychometric support across three drug types. Psychopharmacol (Berl) 227:177\u2013192","journal-title":"Psychopharmacol (Berl)"},{"key":"5991_CR40","doi-asserted-by":"publisher","first-page":"e1084","DOI":"10.1038\/tp.2017.54","volume":"7","author":"F Mueller","year":"2017","unstructured":"Mueller F, Lenz C, Dolder PC, Harder S, Schmid Y, Lang UE, Liechti ME, Borgwardt S (2017) Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects. Transl Psychiatry 7:e1084","journal-title":"Transl Psychiatry"},{"key":"5991_CR41","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.neuroimage.2018.06.068","volume":"179","author":"SD Muthukumaraswamy","year":"2018","unstructured":"Muthukumaraswamy SD, Liley DT (2018) 1\/f electrophysiological spectra in resting and drug-induced states can be explained by the dynamics of multiple oscillatory relaxation processes. Neuroimage 179:582\u2013595","journal-title":"Neuroimage"},{"key":"5991_CR42","doi-asserted-by":"publisher","first-page":"15171","DOI":"10.1523\/JNEUROSCI.2063-13.2013","volume":"33","author":"SD Muthukumaraswamy","year":"2013","unstructured":"Muthukumaraswamy SD, Carhart-Harris RL, Moran RJ, Brookes MJ, Williams TM, Errtizoe D, Sessa B, Papadopoulos A, Bolstridge M, Singh KD, Feilding A, Friston KJ, Nutt DJ (2013) Broadband cortical desynchronization underlies the human psychedelic state. J Neurosci 33:15171\u201315183","journal-title":"J Neurosci"},{"key":"5991_CR43","doi-asserted-by":"publisher","first-page":"e88214","DOI":"10.1371\/journal.pone.0088214","volume":"9","author":"I Neuner","year":"2014","unstructured":"Neuner I, Arrubla J, Werner CJ, Hitz K, Boers F, Kawohl W, Shah NJ (2014) The default mode network and EEG regional spectral power: a simultaneous fMRI-EEG study. PLoS One 9:e88214","journal-title":"PLoS One"},{"key":"5991_CR44","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1124\/pr.115.011478","volume":"68","author":"DE Nichols","year":"2016","unstructured":"Nichols DE (2016) Psychedelics. Pharmacol Rev 68:264\u2013355","journal-title":"Pharmacol Rev"},{"key":"5991_CR45","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1001\/jamapsychiatry.2020.2171","volume":"78","author":"D Nutt","year":"2021","unstructured":"Nutt D, Carhart-Harris R (2021) The current status of psychedelics in psychiatry. JAMA Psychiatry 78:121\u2013122","journal-title":"JAMA Psychiatry"},{"key":"5991_CR46","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/252586a0","volume":"252","author":"L Pieri","year":"1974","unstructured":"Pieri L, Pieri M, Haefely W (1974) LSD as an agonist of dopamine receptors in the striatum. Nature 252:586\u2013588","journal-title":"Nature"},{"key":"5991_CR47","doi-asserted-by":"publisher","first-page":"e0211023","DOI":"10.1371\/journal.pone.0211023","volume":"14","author":"V Polito","year":"2019","unstructured":"Polito V, Stevenson RJ (2019) A systematic study of microdosing psychedelics. PLoS One 14:e0211023","journal-title":"PLoS One"},{"key":"5991_CR48","doi-asserted-by":"crossref","unstructured":"Posner MI (1975) Chapter 15 - Psychobiology of attention. In: Handbook of Psychobiology (Gazzaniga MS, Blakemore C, eds), pp 441-480: Academic Press.","DOI":"10.1016\/B978-0-12-278656-3.50019-3"},{"key":"5991_CR49","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1073\/pnas.1815129116","volume":"116","author":"KH Preller","year":"2019","unstructured":"Preller KH, Razi A, Zeidman P, Stampfli P, Friston KJ, Vollenweider FX (2019) Effective connectivity changes in LSD-induced altered states of consciousness in humans. Proc Natl Acad Sci U S A 116:2743\u20132748","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5991_CR50","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.cub.2016.12.030","volume":"27","author":"KH Preller","year":"2017","unstructured":"Preller KH, Herdener M, Pokorny T, Planzer A, Kraehenmann R, Stampfli P, Liechti ME, Seifritz E, Vollenweider FX (2017) The fabric of meaning and subjective effects in LSD-induced states depend on serotonin 2A receptor activation. Curr Biol 27:451\u2013457","journal-title":"Curr Biol"},{"key":"5991_CR51","doi-asserted-by":"crossref","unstructured":"Preller KH, Burt JB, Ji JL, Schleifer CH, Adkinson BD, Stampfli P, Seifritz E, Repovs G, Krystal JH, Murray JD, Vollenweider FX, Anticevic A (2018) Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor. Elife 7.","DOI":"10.7554\/eLife.35082"},{"key":"5991_CR52","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/npp.2011.228","volume":"37","author":"BB Quednow","year":"2012","unstructured":"Quednow BB, Kometer M, Geyer MA, Vollenweider FX (2012) Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers. Neuropsychopharmacol 37:630\u2013640","journal-title":"Neuropsychopharmacol"},{"key":"5991_CR53","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1146\/annurev-neuro-071013-014030","volume":"38","author":"ME Raichle","year":"2015","unstructured":"Raichle ME (2015) The brain\u2019s default mode network. Annu Rev Neurosci 38:433\u2013447","journal-title":"Annu Rev Neurosci"},{"key":"5991_CR54","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1046\/j.1365-2125.2002.01609.x","volume":"53","author":"J Riba","year":"2002","unstructured":"Riba J, Anderer P, Morte A, Urbano G, Jane F, Saletu B, Barbanoj MJ (2002) Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers. Br J Clin Pharmacol 53:613\u2013628","journal-title":"Br J Clin Pharmacol"},{"key":"5991_CR55","doi-asserted-by":"publisher","first-page":"204512531984577","DOI":"10.1177\/2045125319845774","volume":"9","author":"JM Rocha","year":"2019","unstructured":"Rocha JM, Osorio FL, Crippa JAS, Bouso JC, Rossi GN, Hallak JEC, Dos Santos RG (2019) Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature. Ther Adv Psychopharmacol 9:2045125319845774","journal-title":"Ther Adv Psychopharmacol"},{"key":"5991_CR56","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1001\/archpsyc.1966.01730100099013","volume":"14","author":"E Rodin","year":"1966","unstructured":"Rodin E, Luby E (1966) Effects of LSD-25 on the EEG and photic evoked responses. Arch Gen Psychiatry 14:435\u2013441","journal-title":"Arch Gen Psychiatry"},{"key":"5991_CR57","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1177\/0269881116675512","volume":"30","author":"S Ross","year":"2016","unstructured":"Ross S, Bossis A, Guss J, Agin-Liebes G, Malone T, Cohen B, Mennenga SE, Belser A, Kalliontzi K, Babb J, Su Z, Corby P, Schmidt BL (2016) Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. J Psychopharmacol 30:1165\u20131180","journal-title":"J Psychopharmacol"},{"key":"5991_CR58","doi-asserted-by":"publisher","first-page":"46421","DOI":"10.1038\/srep46421","volume":"7","author":"MM Schartner","year":"2017","unstructured":"Schartner MM, Carhart-Harris RL, Barrett AB, Seth AK, Muthukumaraswamy SD (2017) Increased spontaneous MEG signal diversity for psychoactive doses of ketamine. LSD and psilocybin. Sci Rep 7:46421","journal-title":"LSD and psilocybin. Sci Rep"},{"key":"5991_CR59","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00213-012-2811-0","volume":"225","author":"A Schmidt","year":"2013","unstructured":"Schmidt A, Kometer M, Bachmann R, Seifritz E, Vollenweider F (2013) The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions. Psychopharmacol (Berl) 225:227\u2013239","journal-title":"Psychopharmacol (Berl)"},{"key":"5991_CR60","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.tins.2008.09.012","volume":"32","author":"CE Schroeder","year":"2009","unstructured":"Schroeder CE, Lakatos P (2009) Low-frequency neuronal oscillations as instruments of sensory selection. Trends Neurosci 32:9\u201318","journal-title":"Trends Neurosci"},{"key":"5991_CR61","first-page":"209","volume":"9","author":"C Shagass","year":"1966","unstructured":"Shagass C (1966) Effects of LSD on somatosensory and visual evoked responses and on the EEG in man. Recent Adv Biol Psychiatry 9:209\u2013227","journal-title":"Recent Adv Biol Psychiatry"},{"key":"5991_CR62","doi-asserted-by":"crossref","unstructured":"Szigeti B, Kartner L, Blemings A, Rosas F, Feilding A, Nutt DJ, Carhart-Harris RL, Erritzoe D (2021) Self-blinding citizen science to explore psychedelic microdosing. Elife 10.","DOI":"10.7554\/eLife.62878"},{"key":"5991_CR63","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.cub.2016.02.010","volume":"26","author":"E Tagliazucchi","year":"2016","unstructured":"Tagliazucchi E, Roseman L, Kaelen M, Orban C, Muthukumaraswamy SD, Murphy K, Laufs H, Leech R, McGonigle J, Crossley N, Bullmore E, Williams T, Bolstridge M, Feilding A, Nutt DJ, Carhart-Harris R (2016) Increased global functional connectivity correlates with LSD-induced ego dissolution. Curr Biol 26:1043\u20131050","journal-title":"Curr Biol"},{"key":"5991_CR64","unstructured":"Waldman A (2018) A really good day: how microdosing made a mega difference in my mood, my marriage, and my life: Anchor Books."},{"key":"5991_CR65","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00213-018-5119-x","volume":"236","author":"S Yanakieva","year":"2019","unstructured":"Yanakieva S, Polychroni N, Family N, Williams LTJ, Luke DP, Terhune DB (2019) The effects of microdose LSD on time perception: a randomised, double-blind, placebo-controlled trial. Psychopharmacol (Berl) 236:1159\u20131170","journal-title":"Psychopharmacol (Berl)"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-021-05991-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-021-05991-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-021-05991-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T03:05:55Z","timestamp":1654225555000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-021-05991-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,6]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["5991"],"URL":"https:\/\/doi.org\/10.1007\/s00213-021-05991-9","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,6]]},"assertion":[{"value":"28 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}